Fundraising FoxTavira Therapeutics
1 known investors
Find your way into Tavira Therapeutics
Sign up to see every warm intro you have to Tavira Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tavira Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
Founders & leadership
EH
Els HenckaertsCo-founder
VK
Vibha Kiran TamboliCo-founder
IV
Inge Van HoveCo-founderInge Van Hove is a co-founder of Tavira Therapeutics and brings over 10 years of biotech experience with scientific expertise in neuroscience, ophthalmology, and gene therapy, including contributions to more than 30 peer-reviewed publications.
Investors · 1
Frequently asked questions
- What does Tavira Therapeutics do?
- Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.
- Who founded Tavira Therapeutics?
- Tavira Therapeutics was founded by Els Henckaerts, Benjamien Moeyaert, Veronick Benoy, Vibha Kiran Tamboli, Inge Van Hove.
- Who are Tavira Therapeutics's investors?
- Tavira Therapeutics's investors include GENERAL INCEPTION.